Oklahoma 2022 2022 Regular Session

Oklahoma House Bill HB4056 Amended / Bill

Filed 03/07/2022

                     
 
HB4056 HFLR 	Page 1 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
HOUSE OF REPRESENTATIVES - FLOOR VERSION 
 
STATE OF OKLAHOMA 
 
2nd Session of the 58th Legislature (2022) 
 
COMMITTEE SUBSTITUTE 
FOR 
HOUSE BILL NO. 4056 	By: Marti and Davis 
 
 
 
 
 
COMMITTEE SUBSTITUTE 
 
An Act relating to medical marijuana; amending 63 
O.S. 2021, Section 427.17, w hich relates to the 
Oklahoma Medical Marijuana and Patient Protection 
Act; directing certain labo ratory to provide 
recommendations, standards and operating proce dures 
to the Oklahoma Medical Marijuana Authority; 
directing the Authority to promulgate rule s; 
requiring licensed medical marijuana testing 
laboratories to comply with rules; and declaring an 
emergency. 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2021, Section 427.17, is 
amended to read as follows: 
Section 427.17 A.  There is hereby created a medical marijuana 
testing laboratory license as a category of the medical marijuana 
business license.  The Oklahoma Medical Marijuana Authority is 
hereby enabled to monitor, inspec t and audit a licensed testing 
laboratory under the Oklahoma Medical Marijuana and Patient 
Protection Act.   
 
HB4056 HFLR 	Page 2 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
B. 1. The Authority is hereby authorized to contract with a 
private laboratory for the purpose of conducting complian ce testing 
of medical marijuana t esting laboratories licensed in this state.  
Any such laboratory under contract for compliance testing shall be 
prohibited from conducting any other commercial medical marijuana 
testing in this state.  The laboratory the Au thority contracts with 
for compliance testing shall not employ, or be owned by, the 
following: 
1.  Any  
a. any individual that has a direct or indirect interest 
in a licensed medical marijuana business ;, or 
2.  Any  
b. any individual or his or her spouse, pa rent, child, 
spouse of a child, sibling or spouse of a sibling that 
has an application for a medical marijuana business 
license pending before the Department or is a member 
of the board of directors of a medical m arijuana 
business, or is an individual fina ncially interested 
in any licensee or medical marijuana business located 
within this state. 
2.  The private laboratory under contract with the Authority for 
compliance testing shall provide to the Authority its 
recommendations for brands and models of all equipment and standards 
to be utilized by licensed medical marijuana testing laboratories   
 
HB4056 HFLR 	Page 3 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
when testing samples of medical marijuana, medical marijuana 
concentrate, and medical marijuana product s as well as standard 
operating procedures when extracting and testing medical marijuana, 
medical marijuana concentrate, and medical marijuana product s. The 
recommendations shall be submitted to the Authority no later than 
June 1, 2023. The Authority shall have ninety (90) days from the 
date it receives the recommendations to promulgate new rules or 
modify its current rules for laboratory standards and testing. 
Beginning June 1, 202 4, medical marijuana testing laboratories 
renewing their medical marijuana business license shall be subject 
to and comply with any new or modified rules relating to the testing 
of medical marijuana, medical marijuana concentrate , and medical 
marijuana products.         
C.  The Authority shall develop acceptable testin g practices 
including, but not limited to, testing, standards, quality con trol 
analysis, equipment certificat ion and calibration, and chemical 
identification and substances used. 
D.  A person who is a direct beneficial owne r of a medical 
marijuana dispensary, medical marijuana commer cial grower or medical 
marijuana processor sha ll not be an owner of a laboratory. 
E. A laboratory and a laboratory applicant sha ll comply with 
all applicable local ordinances including , but not limited to, 
zoning, occupancy, licensing and building codes.   
 
HB4056 HFLR 	Page 4 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
F.  A separate license shall be required for e ach specific 
laboratory. 
G.  A medical marijuana testing laboratory license may b e issued 
to a person who performs testin g on medical marijuana and medical 
marijuana products for medical marijuana businesses, m edical 
marijuana research facilities, medical marijuana education 
facilities, and testing on marijuana and marijuana products g rown or 
produced by a patient or caregiver on behalf of a patient, upon 
verification of registration .  A medical marijuana testin g 
laboratory may also conduct research related to the development and 
improvement of its testing practices and procedures. No state-
approved medical marijuana testing facility shall operate unless a 
medical laboratory director is on site during operationa l hours. 
H.  Laboratory applicants and license es shall comply with the 
application requirements of this section and shall submit such other 
information as required for a medical marijuana business applicant, 
in addition to any information the Authority may request for initial 
approval and periodic eva luations during the approval period . 
I.  A medical marijuana testing laboratory may accept samples of 
medical marijuana, medical marijuana concentrate or medical 
marijuana product from a medical marijuana busin ess, medical 
marijuana research facility or me dical marijuana education facility 
for testing purposes only, which purposes may include the provision 
of testing services for samples submitted by a medical marijuana   
 
HB4056 HFLR 	Page 5 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
business for product development .  The Department may require a 
medical marijuana busine ss to submit a sample of medical ma rijuana, 
medical marijuana concentrate or medical marijuana product to a 
medical marijuana testing or quality assurance laboratory upon 
demand. 
J.  A medical marijuana testing laboratory may accept samples of 
medical marijuana, medical marijuana concentrat e or medical 
marijuana product from an individual person for testing only under 
the following conditions: 
1.  The individual person is a patient or caregiver pursuant t o 
the Oklahoma Medical Marijuana and Patient Protecti on Act or is a 
participant in an ap proved clinical or observational study conducted 
by a research facility; and 
2.  The medical marijuana testing laboratory shall require the 
patient or caregiver to produce a v alid patient license and current 
and valid photo identification. 
K.  A medical marijuana testing laboratory may transfer samples 
to another medical marijuana testing laboratory for testing .  All 
laboratory reports provided to or by a medical marijuana busi ness or 
to a patient or caregiver shall identi fy the medical marijuana 
testing laboratory that actually conducted the test. 
L.  A medical marijuana testing laboratory may utilize a 
licensed medical marijuana transporter to transport samples of 
medical marijuana, medical marijuana concentrate and medic al   
 
HB4056 HFLR 	Page 6 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
marijuana product for testing, i n accordance with the Oklahoma 
Medical Marijuana and Patient Protection Act and the rules adopted 
pursuant thereto, between the originating medical marijuana business 
requesting testing services and the destination labora tory 
performing testing services. 
M.  The medical marijuana testing laboratory shall establish 
policies to prevent the existence of or appearance of undue 
commercial, financial or other influences that may dimi nish the 
competency, impartiality and integrit y of the testing processes or 
results of the laboratory, or that may diminish public confidence in 
the competency, impartiality and integrity of the testing processes 
or results of the laboratory .  At a minimum, employees, owners or 
agents of a medical mar ijuana testing laboratory who parti cipate in 
any aspect of the analysis and results of a sample are prohibited 
from improperly influencing the testing process, improperly 
manipulating data or improperly benefit ing from any ongoing 
financial, employment, pe rsonal or business relationship wit h the 
medical marijuana business that provided the sample.  A medical 
marijuana testing laboratory shall not test samples for any medical 
marijuana business in which an owner, employee or agent of the 
medical marijuana te sting laboratory has any form of ow nership or 
financial interest in the medical marijuana business.   
 
HB4056 HFLR 	Page 7 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
N.  The Department, pursuant to rules promulgated by the State 
Commissioner of Health, shall develop standards , policies and 
procedures as necessary for: 
1. The cleanliness and orderliness o f a laboratory premises and 
the location of the laboratory in a secure location, and inspection, 
cleaning and maintenance of any equipment or utensils used for the 
analysis of test samples; 
2.  Testing procedures, testing standards for cannabinoid and 
terpenoid potency and safe levels of contaminants, and remediation 
procedures; 
3.  Controlled access areas for storage of medical marijuana and 
medical marijuana product test samp les, waste and reference 
standards; 
4.  Records to be retained and computer syste ms to be utilized 
by the laboratory; 
5.  The possession, storage and use by the laboratory of 
reagents, solutions and reference standards; 
6.  A certificate of analysis (COA) for each lot of reference 
standard; 
7.  The transport and disposal of unused mari juana, marijuana 
products and waste; 
8.  The mandatory use by a laboratory of an inventory tracking 
system to ensure all harvest and production batches or samples 
containing medical marijuana, medical marijuana concentrat e or   
 
HB4056 HFLR 	Page 8 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
medical marijuana products are identified and tracked from the point 
they are transferred from a medical marijuana business, a patient or 
a caregiver through the point of transfer, destruction or disposal .  
The inventory tracking system reporting shal l include the results of 
any tests that are conducted on medical marijuana, medical marijuana 
concentrate or medical marijuana product; 
9.  Standards of performance; 
10.  The employment of laboratory personnel; 
11.  A written standard operating procedure m anual to be 
maintained and updated by the laboratory; 
12.  The successful participation in a Department -approved 
proficiency testing program for each testing category listed in this 
section, in order to obtain and maintain certification; 
13.  The establishment of and adherence to a quality assurance 
and quality control program to ensure sufficient monitoring of 
laboratory processes and quality of results reported; 
14.  The immediate recall of medical marijuana o r medical 
marijuana products that test above a llowable thresholds or are 
otherwise determined to be unsafe; 
15. The establishment by the laboratory of a system to document 
the complete chain of custody for samples from receipt through 
disposal; 
16. The establishment by the laboratory of a system to retain 
and maintain all required re cords, including business records, and   
 
HB4056 HFLR 	Page 9 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
processes to ensure results are reported in a timely and accurate 
manner; and 
17. Any other aspect of laboratory testing of medical mar ijuana 
or medical marijuana product deemed nec essary by the Department. 
O.  A medical marijuana testing laboratory shall promptly 
provide the Department or designee of the Department access to a 
report of a test and any underlying data that is conducted on a 
sample at the request of a medical marijuan a business or qualified 
patient.  A medical marijuana testing laboratory shall also provide 
access to the Department or designee of the Department to laboratory 
premises and to any material or information reque sted by the 
Department to determine compliance with the requirements of this 
section. 
P.  A medical marijuana testing laboratory shall retain all 
results of laboratory tests conducted on marijuana or products for a 
period of at least seven (7) years and shall make them available to 
the Department upon request. 
Q.  A medical marijuana t esting laboratory shall test samples 
from each harvest batch or product batch, as appropriate, of medical 
marijuana, medical marijuana concentrate and medical marijuana 
product for each of the following categories of test ing, consistent 
with standards developed by the Commissioner: 
1.  Microbials; 
2.  Mycotoxins;   
 
HB4056 HFLR 	Page 10 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
3.  Residual solvents; 
4.  Pesticides; 
5.  Tetrahydrocannabinol (THC) and other cannabinoid potency; 
6.  Terpenoid type and concentration ; and 
7.  Heavy metals. 
R.  A licensed medical marijuana testing laboratory shall test 
each individual harvest batch .  A grower shall separate each harvest 
lot of usable marijuana into harvest batches containing no more tha n 
fifteen (15) pounds, with the exception of any plant mat erial to be 
sold to a licensed proc essor for the purposes of turning the plant 
material into concentrate which may be separated into harvest 
batches of no more than fifty (50) pounds .  A processor shall 
separate each medical marijuana production lot into p roduction 
batches containing no mor e than four (4) liters of concentrate or 
nine (9) pounds for nonliquid products, and for final products, the 
Oklahoma Medical Marijuana Authority shall be authorized to 
promulgate rules on final products as necessary .  Provided, however, 
the Authority shall not require testing of final products less often 
than every one thousand (1,000) grams of THC.  As used in this 
subsection, "final products" shall include, but not be limite d to, 
cookies, brownies, candies, gummies, bev erages and chocolates . 
S.  Medical marijuana testing laboratory licensure shall be 
contingent upon successful on -site inspection, successful   
 
HB4056 HFLR 	Page 11 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
participation in proficiency testing and ongoing compliance with the 
applicable requirements in this section. 
T.  A medical marijuana testing laborato ry shall be inspected 
prior to initial licensure an d up to two (2) times per year 
thereafter by an inspector approved by the Authority .  The Authority 
may enter the licensed p remises of a testing laboratory to conduct 
investigations and additional inspecti ons when the Authority 
believes an investigation or additional inspection is necessary due 
to a possible violation of applicable laws, rules or regulations. 
U.  Medical marijuana testing laboratories shall obtain 
accreditation by an accrediting body approv ed by the Commissioner 
within one (1) year of the date the initial license is issued .  
Renewal of any medical marijuana testing laboratory license shall be 
contingent upon accreditation in accordance with this subsection . 
All medical marijuana testing lab oratories shall obtain 
accreditation prior to applying for and receiving a medical 
marijuana testing laboratory license . 
V.  Unless authorized by the provisions of this sectio n, a 
commercial grower shall not transfer or s ell medical marijuana and a 
processor shall not transfer, sell or process into a concentrate or 
product any medical marijuana, medical marijuana concentrate or 
medical marijuana product unless samples from each harvest batch or 
production batch from which that medical marijuana, medical 
marijuana concentrate or medical marijuana product was derived has   
 
HB4056 HFLR 	Page 12 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
been tested by a medical marijuana testin g laboratory and passed all 
contaminant tests required b y the Oklahoma Medical Marijuana and 
Patient Protection Act and applicable laws, rules and regu lations.  
A licensed commercial grower may transfer medical marijuana that has 
failed testing to a licensed processor only for the purposes of 
decontamination or remediation a nd only in accordance with the 
provisions of the Oklahoma Medical Marijuana and P atient Protection 
Act and the rules and regulations of the Department .  Remediated and 
decontaminated medical marijuana may be returned only to the 
originating licensed commer cial grower. 
W.  Kief shall not be transferred or sold except as authorized 
in the rules and regulations of the Department. 
SECTION 2.  It being immediately necessary for the preservation 
of the public peace, health or safety, an emergency is hereby 
declared to exist, by reason whereof this act shall take effect and 
be in full force from and after its passage an d approval. 
 
COMMITTEE REPORT BY: COMMITTEE ON ALCOHOL, TOBACCO AND CONTROLLED 
SUBSTANCES, dated 03/03/2022 - DO PASS, As Amended and Coauthored.